View of Experience of using alpelisib in the treatment of patients with hormone-sensitive metastatic breast cancer associated with PIK3CA mutation in real clinical practice of the Federal State Budgetary Institution National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation | Voprosy onkologii

← Experience of using alpelisib in the treatment of patients with hormone-sensitive metastatic breast cancer associated with PIK3CA mutation in real clinical practice of the Federal State Budgetary Institution National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation